ArticleInnovations in pharmacy2019

Additional Utility of Pharmacogenomics (PGx) Panel Testing in a CYP2D6 Normal Metabolizer with a History of Breast Cancer.

Michael J SchuhPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.